4th Edition of International Heart Congress
June 22-24,2026 | Hybrid Event
Vein Graft Disease
Vein graft disease is a condition that often arises after coronary artery bypass surgery, where a vein from the patient's leg is used to create a bypass around a blocked coronary artery. Over time, these grafts can undergo pathological changes, leading to the development of vein graft disease. The process involves a series of complex events, including inflammation, oxidative stress, and the formation of atherosclerotic plaques within the graft. As vein graft disease progresses, it can compromise blood flow to the heart, ultimately impacting the success of the bypass procedure. Researchers and clinicians focus on understanding the molecular and cellular mechanisms underlying vein graft disease to develop strategies for prevention and intervention, aiming to improve the long-term outcomes of coronary artery bypass grafting procedures.
Shuping Zhong
University of Southern California, United States
Ahdy Wadie Helmy
Indiana University School of Medicine, United States
Federico Benetti
Benetti Foundation, Argentina
Samir Rafla
Alexandria University, Egypt
Mekhman N Mamedov
National Research Center for Preventive Medicine, Russian Federation
Ahdy Wadie Helmy
Indiana University School of Medicine, United States
Federico Benetti
Benetti Foundation, ArgentinaSubmit your abstract Today
Title : Fats of Life, the skinny on statins and beyond !
Ahdy Wadie Helmy, Indiana University School of Medicine, United States
Title : Pharmacological advancement in pulmonary arterial hypertension treatment - Contribution of treprostinil dry-powder formulation
Miroslav Radenkovic, University of Belgrade, Serbia
Title : Personalized and Precision Medicine (PPM) and PPN-guided cardiology practice as a unique model via translational applications and upgraded business modeling to secure human healthcare, wellness and biosafety
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Cardiovascular nanomedicine: Stopping strokes, unclogging arteries and restoring heart function
Thomas J Webster, Hebei University of Technology, China
Title : Antibodies with functionality as a new generation of translational tools designed to monitor autoimmune myocarditis at clinical and subclinical stages
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Perception of cardiovascular risk in women after a rehabilitation program
Maria Teresa Carvallo Marin, Privado, Chile